These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 2519875

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [Abstract] [Full Text] [Related]

  • 25. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P, Lindahl C, Bergh A.
    Prostate; 2005 Feb 01; 62(2):148-64. PubMed ID: 15389804
    [Abstract] [Full Text] [Related]

  • 26. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
    Drago JR, Goldman LB, Maurer RE, Eckels DD, Gershwin ME.
    J Natl Cancer Inst; 1980 Apr 01; 64(4):931-7. PubMed ID: 6929004
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ.
    Clin Cancer Res; 1996 Sep 01; 2(9):1627-36. PubMed ID: 9816342
    [Abstract] [Full Text] [Related]

  • 29. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

  • 30. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase.
    Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H.
    Cancer Res; 1999 May 01; 59(9):2115-20. PubMed ID: 10232597
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 2006 Jul 01; 12(13):4072-9. PubMed ID: 16818707
    [Abstract] [Full Text] [Related]

  • 33. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
    Neubauer BL, McNulty AM, Chedid M, Chen K, Goode RL, Johnson MA, Jones CD, Krishnan V, Lynch R, Osborne HE, Graff JR.
    Cancer Res; 2003 Sep 15; 63(18):6056-62. PubMed ID: 14522935
    [Abstract] [Full Text] [Related]

  • 34. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA, Harakidas P, Bowlin T, Attardo G.
    Cancer Res; 1998 Aug 01; 58(15):3461-5. PubMed ID: 9699681
    [Abstract] [Full Text] [Related]

  • 35. Spontaneous mammary tumors in aging Noble rats.
    Cheung SY, Choi HL, James AE, Chen ZY, Huang Y, Chan FL.
    Int J Oncol; 2003 Feb 01; 22(2):449-57. PubMed ID: 12527947
    [Abstract] [Full Text] [Related]

  • 36. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
    Pollack A, Block NL, Stover BJ, Irvin GL.
    Cancer Res; 1985 Mar 01; 45(3):1052-7. PubMed ID: 3971360
    [Abstract] [Full Text] [Related]

  • 37. The activity of epitestosterone in hormone dependent prostate tumour models.
    Maucher A, von Angerer E, Hampl R, Stárka L.
    Endocr Regul; 1994 Mar 01; 28(1):23-9. PubMed ID: 7949009
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
    Zeng Y, Yokohira M, Saoo K, Takeuchi H, Chen Y, Yamakawa K, Matsuda Y, Kakehi Y, Imaida K.
    Carcinogenesis; 2005 Jun 01; 26(6):1109-16. PubMed ID: 15731164
    [Abstract] [Full Text] [Related]

  • 39. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E, Bernoulli J, Talvitie EM, Santti R.
    Int J Androl; 2009 Aug 01; 32(4):399-410. PubMed ID: 19515173
    [Abstract] [Full Text] [Related]

  • 40. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A, Jones J, Pietras K, Kilter S, Skytt A, Rudolfsson SH, Bergh A.
    Prostate; 2007 Nov 01; 67(15):1664-76. PubMed ID: 17854058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.